On May 9, 2025, Ms. Cai Ping from Shenzhen Beimeikang Biotechnology (CLOC) was invited to attend the "20+8" Pharmaceuticals and Medical Devices Industry Salon in Shenzhen. She joined representatives from the government, industry, academia, and research sectors to explore the "Shenzhen's Support Measures for the complete supply Chain of Pharmaceuticals and Medical Devices" . The new policy covers all aspects such as R&D, approval, production, and globalization. It establishes a special channel for AI medical devices, supports intelligent pet medical devices for the first time.
For enterprises deeply engaged in the track of AI - innovative medical devices, this "policy package" precisely addresses the industry's pain points. The green channel for intelligent review will accelerate the product launch process, the clinical research collaborative platform will open up the path for medical - industrial transformation, and the cross - border trade service platform will build a fast track for "Made in Shenzhen" to go global. It is particularly noteworthy that the policy includes AI pet medical devices in the key support category for the first time, encouraging efforts into the mass market.
